Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AAE581 in Postmenopausal Women With Osteopenia/Osteoporosis
jRCT2080220152Phase 2
- Sponsor
- Novartis
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of balicatib in osteoporosis and osteopenia, sponsored by Novartis.
02
Drugs
balicatib
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on jRCT2080220152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220152.